Effect of Eligibility Criteria on Patients' Survival and Serious Adverse Events in Colorectal Cancer Drug Trials
Wang, C.; Chen, A.; HE, X.; Guo, Y.; Balian, P.; George, T. J.; Bian, J.; Wang, F.
Show abstract
This study investigates the impact of clinical trial eligibility criteria on patient survival and serious adverse events (SAEs) in colorectal cancer (CRC) drug trials using real-world data. We utilized the OneFlorida+ networks data repository, conducting a retrospective analysis of CRC patients receiving FDA-approved first-line metastatic treatments. Propensity score matching created balanced case-control groups, which were evaluated using survival analysis and machine learning algorithms to assess the effects of eligibility criteria. Our study included 68,375 patients, with matched case-control groups comprising 1,126 patients each. Survival analysis revealed ethnicity and race, along with specific medical history (eligibility criteria), as significant survival outcome predictors. Machine learning models, particularly the XgBoost regressor, were employed to analyze SAEs, indicating that age and study groups were notable factors in SAEs occurrence. The studys findings highlight the importance of considering patient demographics and medical history in CRC trial designs.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Survival benefits of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma: evidence from a SEER-based retrospective cohort study 94%
- Safety and effectiveness of RBD-specific polyclonal equine F(ab′)2 fragments for the treatment of hospitalized patients with severe Covid-19 disease: a retrospective cohort study 93%
- Analysis of clinical trial registry entry histories using the novel R package cthist 92%
Similar papers in this journal
- Use of unstructured text in prognostic clinical prediction models: a systematic review 93%
- Clinical Utility of Automatable Prediction Models for Improving Palliative and End-Of-Life Care Outcomes: Towards Routine Decision Analysis Before Implementation 93%
- A Web-based Tool for Automatically linking Clinical Trials to their Publications 92%
Similar papers in this journal
- An Informatics Consult approach for generating clinical evidence for treatment decisions 92%
- Combining structured and unstructured data in eMRs to create clinically-defined eMR-derived cohorts 92%
- On the predictability of postoperative complications for cancer patients: a Portuguese cohort study 92%
Similar papers in this journal
- COVID-19 Outcomes in Patients with Cancer: Findings from the University of California Health System Database 93%
- Circulating serum miRNAs predict response to platinum chemotherapy in high-grade serous ovarian cancer 92%
- Sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors on new-onset overall cancer in type 2 diabetes mellitus: a population-based study 92%
Similar papers in this journal
- Empirical Sample Size Determination for Popular Classification Algorithms in Clinical Research 92%
- Optimal policy determination in sequential systemic and locoregional therapy of oropharyngeal squamous carcinomas: A patient-physician digital twin dyad with deep Q-learning for treatment selection 92%
- Machine Learning to Predict Mortality and Critical Events in COVID-19 Positive New York City Patients 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.